Baicalin clearly ameliorates pulmonary hypertension, pulmonary arterial remolding, and hypoxic cor pulmonale induced by hypoxia by inhibiting the p38 MAPK signaling pathway and MMP-9 expression. This evidence concerns the gene MMP9 and cor pulmonale.